9Z9-80869-27471
5 vaccinations
8 coded responses
51 check-ins
8 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 451 / OH
- Registered
- 2021-02-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-06
Registered in v-safe
-
2021-02-06
Dose 1 — Pfizer-BioNTech
-
2021-02-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-13
-
2021-02-20
Survey response — day 14, dose 1MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Mild lupus flare of severe fatigue on 2/18 and 2/19. A little better today (2/20), not back to 100% yet.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-27
Dose 2 — Pfizer-BioNTech
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
-
2021-03-06
Survey response — day 7, dose 2MedDRA: Pre-existing disease, Systemic lupus erythematosus — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Mild to moderate lupus flairMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-13
-
2021-03-20
Survey response — day 21, dose 2MedDRA: Fatigue, Pain, Pre-existing disease, Systemic lupus erythematosus — Feeling: Good · Be unable to do your normal daily activitiesFree text: Mild Lupus flare of pain and fatigue.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-27
- 2021-04-03
- 2021-04-10
- 2021-05-29
-
2021-08-28
Survey response — 6 months, dose 2MedDRA: Arthritis, Bursitis, Condition aggravated, Office visit, Pre-existing disease, Rotator cuff syndrome — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Major increase in frequency of autoimmune condition (UMCTD] flares. Torn rotator cuff with bursitis and arthritis. · Healthcare visit (other): Doctors officesMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-28
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-09-17
Dose 3 — Pfizer-BioNTech
- 2021-09-17
- 2021-09-18
- 2021-09-20
- 2021-09-21
-
2021-09-22
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-09-23
-
2021-09-24
Survey response — day 7, dose 3MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Joint pains, Fatigue or tirednessFree text: Autoimmune flareMedDRA releases: 2024-11 · check-in free text available
- 2021-10-01
- 2021-10-08
- 2021-10-15
- 2021-10-23
- 2021-10-29
- 2021-12-14
- 2021-12-19
-
2022-03-18
Survey response — 6 months, dose 3MedDRA: Arthralgia, Condition aggravated, Office visit, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Left knee pain (osteo, torn meniscus and bakers cyst) no longer responds to cortizone. · Healthcare visit (other): In officeMedDRA releases: 2024-11 · check-in free text available
-
2022-03-18
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-03-21
-
2022-03-28
Dose 4 — Pfizer-BioNTech
- 2022-04-14
- 2022-04-18
- 2022-04-25
- 2022-05-02
-
2022-05-09
Survey response — day 42, dose 4MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: UCTD flareMedDRA releases: 2024-11 · check-in free text available
- 2022-06-27
-
2022-09-23
Dose 5 — Pfizer-BioNTech
- 2022-09-28
- 2022-10-09
- 2022-10-15
- 2022-10-22
- 2022-10-28
- 2022-11-04
-
2022-12-23
Survey response — 3 months, dose 5MedDRA: Asthma, Brain fog, COVID-19, Cough, Fatigue, Glossodynia, Pain, Pre-existing disease, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Positive for covid - full body ache, cough, head congestion, brain fog, tongue very sore, extreme fatigue, asthma flare upMedDRA releases: 2024-11 · check-in free text available
-
2022-12-23
Report sent to call center — 3 months, dose 5Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-12-27
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-12-27
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-12-27
Call successfulCompleted over the phone
- 2023-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-06 | Pfizer-BioNTech | |
| 2 | 2021-02-27 | Pfizer-BioNTech | |
| 3 | 2021-09-17 | Pfizer-BioNTech | No |
| 4 | 2022-03-28 | Pfizer-BioNTech | No |
| 5 | 2022-09-23 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 successful
VAERS report filed, before or during a call: 1
1 wait over 3 months for a first call
Free text
Release 4 — day 14, dose 1
Symptoms: Mild lupus flare of severe fatigue on 2/18 and 2/19. A little better today (2/20), not back to 100% yet.
Release 5 — day 7, dose 2
Systemic reaction (other): Mild to moderate lupus flair
Release 6 — day 21, dose 2
Symptoms: Mild Lupus flare of pain and fatigue.
Release 9 — 6 months, dose 2
Symptoms: Major increase in frequency of autoimmune condition (UMCTD] flares. Torn rotator cuff with bursitis and arthritis.
Healthcare visit (other): Doctors offices
Release 9 — day 7, dose 3
Systemic reaction (other): Autoimmune flare
Release 11 — 6 months, dose 3
Symptoms: Left knee pain (osteo, torn meniscus and bakers cyst) no longer responds to cortizone.
Healthcare visit (other): In office
Release 11 — day 42, dose 4
Symptoms: UCTD flare
Release 12 — 3 months, dose 5
Symptoms: Positive for covid - full body ache, cough, head congestion, brain fog, tongue very sore, extreme fatigue, asthma flare up
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Arthritis | ✓ | · | ✓ |
| SD | Asthma | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Bursitis | ✓ | · | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Glossodynia | · | · | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rotator cuff syndrome | ✓ | · | ✓ |
| SD | Systemic lupus erythematosus | ✓ | ✓ | ✓ |
| SRO | Condition aggravated | · | · | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Systemic lupus erythematosus | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release